Mednax Inc Stock News

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Mednax to Present at 2022 J.P. Morgan Global High Yield and Leveraged Finance Conference

Mednax's (MD) Q4 results improve on better revenues and expanded patient volumes.

Mednax Inc (NYSE: MD ) reports Q4 adjusted EPS of $0.52 , more than double from $0.25 a year ago and beating the consensus of $0.44. Q4 revenues reached $498.5 million, compared to $416.6 million for the prior-year period and beating the consensus of $483.83 million. Mednax''s overall same-unit revenue increased by 17.6%, modestly complemented by net acquisition activity. Same-unit revenue from net reimbursement-related … Full story available on Benzinga.com

MEDNAX, Inc. (MD) CEO Mark Ordan on Q4 2021 Results - Earnings Call Transcript

Mednax is a leading provider of physician services including newborn, maternal-fetal, pediatric cardiology and other pediatric subspecialty care. Our national network is comprised of affiliated physicians who provide clinical care in 38 states and Puerto Rico. At December 31, 2021, our national network comprised over 2,400 affiliated physicians,… The post MEDNAX, INC. – 10-K – MANAGEMENT''S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS appeared first on InsuranceNewsNet .

Mednax found using ticker (MD) now have 11 analysts in total covering the stock. The consensus rating is ''Hold''. The target price ranges between 32 and 14 calculating the average target price we see 27.36. Now with the previous closing price of 25.42 this is indicating there is a potential upside of 7.6%. The day 50 moving average is 25.84 and the 200 day MA is 28.68. The market capitalisation for the company is $2,225m. You can visit the company''s website by visiting: https://www.mednax.com [stock_market_widget type="chart" symbol="MD" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] The potential market cap would be $2,395m based on the market concensus. MEDNAX, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

Mednax press release (MD): Q4 Non-GAAP EPS of $0.52 beats by $0.09.Revenue of $499M (+19.7% Y/Y) beats by $16.5M.On a preliminary basis, Mednax anticipates that its 2022…

Mednax (MD) delivered earnings and revenue surprises of 18.18% and 3.01%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Mednax to Present at SVB Leerink 11th Annual Global Healthcare Conference

Mednax (NYSE:MD) is scheduled to announce Q4 earnings results on Thursday, February 17th, before market open.The consensus EPS Estimate is $0.43 (+72.0% Y/Y) and the consensus…

Carlyle Group <> has named Linda Hefner Filler, a former Walgreen (WBA) executive, and Mednax (MD) CEO Mark Ordan to its board, effective April 1, 2022.Meanwhile, Janet Hill…

Mednax's (MD) fourth-quarter results are likely to reflect growth in same-unit revenues and NICU days.

Mednax (MD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.